tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Rick Bienkowski, 5 are a HOLD (19.23%), 21 are a BUY (80.77%).
Analyst Rick Bienkowski works at CANTOR FITZGERALD with a stock forecast success ratio of 8.89% fulfilled within 25.2 days on average.
Rick Bienkowski’s has documented 52 price targets and ratings displayed on 5 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on BEAM, Beam Therapeutics at 17-Oct-2023.
Analyst best performing recommendations are on VERV (VERVE THERAPEUTICS).
The best stock recommendation documented was for VERV (VERVE THERAPEUTICS) at 2/1/2023. The price target of $21 was fulfilled within 8 days with a profit of $1.07 (4.85%) receiving and performance score of 6.06.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
57
$34.26 (150.66%)
48
2 days ago
3/6 (50%)
$33.53 (142.86%)
153
Buy
57
$34.26 (150.66%)
66
29 days ago
2/4 (50%)
$23.04 (67.84%)
4
Hold
42
$19.26 (84.70%)
26
1 months 28 days ago
7/7 (100%)
$-1.61 (-3.69%)
164
Hold
35
$12.26 (53.91%)
42
1 months 28 days ago
3/3 (100%)
$-8.61 (-19.74%)
114
Buy
40
$17.26 (75.90%)
75
2 months 27 days ago
3/5 (60%)
$11.71 (41.39%)
237
What Year was the first public recommendation made by Rick Bienkowski?
